SP
Symmetry Partners’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
15,224
+453
| +3% | +$39.5K | 0.16% | 55 |
|
|
2025
Q1 | $1.01M | Buy |
14,771
+21
| +0.1% | +$1.43K | 0.14% | 61 |
|
|
2024
Q4 | $1.15M | Sell |
14,750
-14
| -0.1% | -$1.09K | 0.16% | 57 |
|
|
2024
Q3 | $990K | Buy |
+14,764
| New | +$990K | 0.23% | 47 |
|
|
2024
Q2 | – | Sell |
-1,454
| Closed | -$202K | – | 523 |
|
|
2024
Q1 | $202K | Buy |
+1,454
| New | +$202K | 0.02% | 530 |
|
|
2023
Q3 | – | Sell |
-1,882
| Closed | -$242K | – | 539 |
|
|
2023
Q2 | $242K | Hold |
1,882
| – | – | 0.01% | 512 |
|
|
2023
Q1 | $219K | Hold |
1,882
| – | – | 0.01% | 519 |
|
|
2022
Q4 | $213K | Buy |
+1,882
| New | +$213K | 0.01% | 524 |
|
|
2022
Q3 | – | Sell |
-3,536
| Closed | -$264K | – | 553 |
|
|
2022
Q2 | $264K | Buy |
3,536
+2,652
| +300% | +$198K | 0.02% | 485 |
|
|
2022
Q1 | $452K | Hold |
884
| – | – | 0.03% | 384 |
|
|
2021
Q4 | $475K | Hold |
884
| – | – | 0.03% | 408 |
|
|
2021
Q3 | $478K | Hold |
884
| – | – | 0.03% | 423 |
|
|
2021
Q2 | $377K | Buy |
884
+170
| +24% | +$72.5K | 0.03% | 524 |
|
|
2021
Q1 | $257K | Sell |
714
-386
| -35% | -$139K | 0.02% | 589 |
|
|
2020
Q4 | $407K | Sell |
1,100
-133
| -11% | -$49.2K | 0.03% | 439 |
|
|
2020
Q3 | $508K | Buy |
1,233
+520
| +73% | +$214K | 0.04% | 315 |
|
|
2020
Q2 | $289K | Buy |
+713
| New | +$289K | 0.04% | 239 |
|
|
2019
Q2 | – | Sell |
-2,959
| Closed | -$352K | – | 354 |
|
|
2019
Q1 | $352K | Buy |
2,959
+2,080
| +237% | +$247K | 0.06% | 214 |
|
|
2018
Q4 | $105K | Buy |
+879
| New | +$105K | 0.03% | 328 |
|